1. Home
  2. SSKN vs AYTU Comparison

SSKN vs AYTU Comparison

Compare SSKN & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSKN
  • AYTU
  • Stock Information
  • Founded
  • SSKN 1989
  • AYTU N/A
  • Country
  • SSKN United States
  • AYTU United States
  • Employees
  • SSKN N/A
  • AYTU N/A
  • Industry
  • SSKN Medical/Dental Instruments
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSKN Health Care
  • AYTU Health Care
  • Exchange
  • SSKN Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • SSKN 9.7M
  • AYTU 9.6M
  • IPO Year
  • SSKN 2005
  • AYTU N/A
  • Fundamental
  • Price
  • SSKN $2.45
  • AYTU $2.20
  • Analyst Decision
  • SSKN Strong Buy
  • AYTU Strong Buy
  • Analyst Count
  • SSKN 1
  • AYTU 2
  • Target Price
  • SSKN $6.00
  • AYTU $10.00
  • AVG Volume (30 Days)
  • SSKN 18.4K
  • AYTU 208.6K
  • Earning Date
  • SSKN 08-13-2025
  • AYTU 05-14-2025
  • Dividend Yield
  • SSKN N/A
  • AYTU N/A
  • EPS Growth
  • SSKN N/A
  • AYTU N/A
  • EPS
  • SSKN N/A
  • AYTU N/A
  • Revenue
  • SSKN $33,620,000.00
  • AYTU $81,659,000.00
  • Revenue This Year
  • SSKN $3.31
  • AYTU N/A
  • Revenue Next Year
  • SSKN $9.67
  • AYTU $8.68
  • P/E Ratio
  • SSKN N/A
  • AYTU $11.94
  • Revenue Growth
  • SSKN 3.30
  • AYTU 0.41
  • 52 Week Low
  • SSKN $2.10
  • AYTU $0.95
  • 52 Week High
  • SSKN $3.80
  • AYTU $2.88
  • Technical
  • Relative Strength Index (RSI)
  • SSKN 50.75
  • AYTU 62.85
  • Support Level
  • SSKN $2.30
  • AYTU $2.04
  • Resistance Level
  • SSKN $2.66
  • AYTU $2.45
  • Average True Range (ATR)
  • SSKN 0.21
  • AYTU 0.13
  • MACD
  • SSKN 0.02
  • AYTU 0.01
  • Stochastic Oscillator
  • SSKN 28.99
  • AYTU 68.00

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Share on Social Networks: